Atherosclerotic stenos of renal arteries at patients with diabetes mellitus and arterial hypertension.

Abstract


Problems of diagnostics and treatment of ischemic renal disease (atherosclerotic stenosis of renal arteries) at patients with diabetes mellitus
are discussed.

References

  1. Mourad JJ, Le Jeune S. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress. J Hypertens Suppl 2008; 26 (3): S7-13.
  2. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999; 341: 1127-33.
  3. Mogensen CE. The kidney in diabetes: how to control renal and related cardiovascular complications. Am J Kidney Dis 2001; 37: S2-S6.
  4. Дедов И.И., Шестакова М.В. Диабетическая нефропатия. М.: Универсум паблишинг, 2000.
  5. Yokoyama H, Okudaira M, Otani T et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int 2000; 58 (1): 302-11.
  6. Harvey JN. Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes. Curr Opin Nephrol Hypertens 2003; 12 (3): 317-22.
  7. Оганов Р.Г., Лепахин В.К., Фитилев С.Б. и др. Качество профилактики и лечения сердечно-сосудистых заболеваний и их осложнений у больных сахарным диабетом 2 типа в амбулаторных условиях. Кардиоваск. тер. и проф. 2008; 7 (7): 9-14.
  8. Lippert J, Ritz E, Schwarzbeck A, Schneider P. The rising tide of endstage renal failure from diabetic nephropathy type II - an epidemiological analysis. Nephrol Dial Transplant 1995; 10 (4): 462-7.
  9. Dzielinska Z, Januszewicz A, Demkow M et al. Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens 2007; 25 (3): 663-70.
  10. Alcasar JM, Marin R, Gomez-Campdera F et al. Clinical charasteristics of ischaemic renal disease. Nephrol Dial Transplant 2001; 16 (Suppl. 1): 74-7.
  11. Sawicki PT, Kaiser S, Heinemann L et al. Prevalence of renal artery stenosis in diabetes mellitus - an autopsy study. J Intern Med 1991; 229 (6): 489-92.
  12. CourrПges JP, Bacha J, Aboud E. Prevalence and profile of renovascular disease in type II diabetic patients with severe hypertension. Arch Mal Coeur Vaiss 1997; 90 (8): 1059-63.
  13. Courreges JP, Bacha J, Aboud E, Pradier P. Prevalence of renal artery stenosis in type 2 diabetes. Diabetes Metab 2000; 26 (Suppl. 4): 90-6.
  14. Valabhji J, Robinson S, Poulter C et al. Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care 2000; 23: 539-43.
  15. Kuroda S, Nishida N, Uzu T et al. Prevalence if renal artery stenosis in autopsy patients with stroke. Stroke 2000; 31: 61-5.
  16. Horita Y, Tadokoro M, Taura K et al. Relationship between carotid artery intima-media thickness and atherosclerotic renal artery stenosis in type 2 diabetes with hypertension. Kidney Blood Press Res 2002; 25: 255-9.
  17. Kuczera P, Wloszczynska E, Adamczak M et al. Frequency of renal artery stenosis and variants of renal vascularization in hypertensive patients: analysis of 1550 angiographies in one centre. J Hum Hypertens 2009; 23 (6): 396-401.
  18. Horita Y, Tadokoro M, Taura K et al. Relationship between carotid artery intima-media thickness and atherosclerotic renal artery stenosis in type 2 diabetes with hypertension. Kidney Blood Press Res 2002; 25 (4): 255-9.
  19. Vachharajani TJ, Dacie JE, Yaqoob MM et al. Detection of occult renovascular disease in unexplained chronic kidney disease. Int Urol Nephrol 2005; 37 (4): 793-6.
  20. Фомин В.В. Ишемическая болезнь почек: клиническая картина, патогенез, тактика ведения. Автореф. дис. ... докт. мед. наук. М., 2008.
  21. Domrongkitchaiporn S, Sritara P, Kitiyakara C et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 2005; 16: 791-9.
  22. Stehouwer CD. Endothelial dysfunction in diabetic nephropathy: state of art and potential significance for non-diabetic renal disease. Nephrol Dial Transplant 2004; 19: 778-81.
  23. Шестакова М.В., Ярек-Мартынова И.Р., Иванишина Н.С. и др. Кардиоренальный синдром при сахарном диабете 1 типа: роль дисфункции эндотелия. Кардиология. 2005; 6: 35-41.
  24. Гордеев А.В. Патология почек у больных сахарным диабетом 2 типа пожилого возраста. Автореф. дис. ... докт. мед. наук. М., 2002.
  25. Фомин В.В., Моисеев С.В., Швецов М.Ю. и др. Ишемическая болезнь почек и сочетанные хронические нефропатии: клинические и прогностические особенности. Тер. арх. 2007; 6: 44-9.
  26. Myers DI, Poole LJ, Imam K et al. Renal artery stenosis by three-dimensional magnetic resonance angiography in type 2 diabetics with uncontrolled hypertension and chronic renal insufficiency: prevalence and effect on renal function. Am J Kidney Dis 2003; 41 (2): 351-9.
  27. Ramos F, Kotliar C, Alvarez D et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int 2003; 63: 276-82.
  28. Alhadad A, Mattiasson I, Ivancev K et al. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis. Int Angiol 2009; 28 (2): 106-12.
  29. Mistry S, Ives N, Harding J et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens 2007; 21 (7): 511-5.
  30. Kitazawa M, Tamamura H, Nakano S et al. Treatment of renovascular hypertension using stent implantation in an elderly patient with NIDDM. Intern Med 2000; 39: 464-7.
  31. Zeller T, Muller C, Frank U et al. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter Cardiovasc Interv 2003; 58: 510-5.
  32. Silva JA, Potluri S, White CJ et al. Diabetes mellitus does not preclude stabilization or improvement of renal function after stent revascularization in patients with kidney insufficiency and renal artery stenosis. Catheter Cardiovasc Interv 2007; 69 (6): 902-7.
  33. Davies MG, Saad WE, Peden EK et al. Implications of acute functional injury following percutaneous renal artery intervention. Ann Vasc Surg 2008; 22 (6): 783-9.
  34. Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 2006; 29 (2): 84-93.
  35. Vignali C, Bargellini I, Lazzereschi M et al. Predictive factors of in-stent restenosis in renal artery stenting: a retrospective analysis. Cardiovasc Intervent Radiol 2005; 28 (3): 296-302.
  36. Shammas NW, Kapalis MJ, Dippel EJ et al. Clinical and angiographic predictors of restenosis following renal artery stenting. J Invasive Cardiol 2004; 16: 10-3.
  37. Symonides B, Januszewicz A, Rowinski O et al. Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis. J Cardiovasc Risk 1999; 6 (4): 269-72.
  38. Silva JA. Evaluation and approach to treatment of renal artery stenosis in patients with diabetic nephropathy. Curr Diab Rep 2008; 8 (6): 494-8.
  39. Rundback J. Renal revascularization in diabetics: few facts, firm convictions, forward momentum. Catheter Cardiovasc Interv 2007; 69 (6): 908-9.
  40. Российское медицинское общество по артериальной гипертонии - Всероссийское научное общество кардиологов. Диагностика и лечение артериальной гипертензии. Российские рекомендации (3-й пересмотр). М., 2008.
  41. Staessen JA, Li Y, Richart T. Oral renin inhibitors. Lancet 2006; 368: 1449-56.

Statistics

Views

Abstract - 102

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies